Cargando…
Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8(+) T cell responses
Influenza vaccines that can be administered intranasally or by other needle-free delivery routes have potential advantages over injected formulations in terms of patient compliance, cost, and ease of global distribution. Supramolecular peptide nanofibers have been investigated previously as platform...
Autores principales: | Si, Youhui, Wen, Yi, Kelly, Sean H., Chong, Anita S., Collier, Joel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309200/ https://www.ncbi.nlm.nih.gov/pubmed/29673645 http://dx.doi.org/10.1016/j.jconrel.2018.04.031 |
Ejemplares similares
-
Adjuvant-free nanofiber vaccine induces in situ lung dendritic cell activation and T(H)17 responses
por: Si, Youhui, et al.
Publicado: (2020) -
Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses
por: Wu, Yaoying, et al.
Publicado: (2022) -
Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation
por: Chen, Jui-Lin, et al.
Publicado: (2022) -
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung
por: Morabito, Kaitlyn M., et al.
Publicado: (2016) -
Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)